WHO resumes hydroxychloroquine drug trial in COVID-19
The coronavirus disease (COVID-19) has rippled across the world with a devastating effect. As scientists raced to find an effective treatment for patients, existing malaria and rheumatoid arthritis drug hydroxychloroquine became one of the most popular candidates.
No hay comentarios:
Publicar un comentario